CHEK1 and melanoma: Interestingly one recent report showed that the CDC42 homologue RhoJ and its effector PAK1 modulate ATR activity via degradation of claspin after DNA damage thereby uncoupling ATR from Chk1; moreover RhoJ appears to be upregulated in advanced melanoma [49].